Stay updated on OPTIMISE Clinical Trial: Secukinumab in Psoriasis

Sign up to get notified when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.
Latest website image capture
Clouds background image

Latest updates to the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.6%
    Check dated 2025-03-03T22:22:17.000Z thumbnail image
  3. Check
    26 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.6%
    Check dated 2025-02-10T09:45:52.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.0%
    Check dated 2025-02-03T07:22:35.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-19T21:51:23.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.
    Difference
    0.1%
    Check dated 2025-01-12T17:17:47.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.0%
    Check dated 2024-12-14T22:33:12.000Z thumbnail image

Stay in the know with updates to OPTIMISE Clinical Trial: Secukinumab in Psoriasis

Enter your email address, and we'll notify you when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.